Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients

BACKGROUND: The neutrophil–lymphocyte ratio (NLR) has been proposed as an indicator of systemic inflammatory response. Several studies suggest a negative impact of increased NLR for patient's survival in different types of cancer. However, previous findings from small-scale studies revealed con...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichler, M, Hutterer, G C, Stoeckigt, C, Chromecki, T F, Stojakovic, T, Golbeck, S, Eberhard, K, Gerger, A, Mannweiler, S, Pummer, K, Zigeuner, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590665/
https://www.ncbi.nlm.nih.gov/pubmed/23385728
http://dx.doi.org/10.1038/bjc.2013.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590665/
https://www.ncbi.nlm.nih.gov/pubmed/23385728
http://dx.doi.org/10.1038/bjc.2013.28

Ejemplares similares